search
Back to results

Efficacy Study to Evaluate Laparoscopic Fascial Closure Device

Primary Purpose

Hernia, Abdominal

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Port Close
Sponsored by
Stanford University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hernia, Abdominal

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:- Clinical Diagnosis of Morbid Obesity

  • BMI > 40 or BMI > 35 with medical comorbidities
  • Undergoing laparoscopic gastric surgery
  • Have at least one trocar site measuring 12 mm or greater Exclusion Criteria:Vulnerable subjects will be excluded including:

    1. Children
    2. Pregnant women
    3. Economically and educationally disadvantaged
    4. Decisionally impaired
    5. Homeless people
    6. Employees and students.

Sites / Locations

  • Stanford University School of Medicine

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Gastric Bypass Surgery Patients

Arm Description

Surgical site closure using Port Close device

Outcomes

Primary Outcome Measures

Count of Participants With Successful Port Site Closure Using Port Close Device
Time of Port Site Closure

Secondary Outcome Measures

Full Information

First Posted
November 13, 2009
Last Updated
September 15, 2017
Sponsor
Stanford University
Collaborators
SurgSolutions, LLC
search

1. Study Identification

Unique Protocol Identification Number
NCT01024296
Brief Title
Efficacy Study to Evaluate Laparoscopic Fascial Closure Device
Official Title
Pivotal Study to Evaluate the Efficacy of a Laparoscopic Port Closure Device
Study Type
Interventional

2. Study Status

Record Verification Date
September 2017
Overall Recruitment Status
Completed
Study Start Date
July 2009 (Actual)
Primary Completion Date
March 2010 (Actual)
Study Completion Date
March 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Stanford University
Collaborators
SurgSolutions, LLC

4. Oversight

5. Study Description

Brief Summary
During any minimally invasive surgery case, 5-25mm size incisions need to be made to gain access to the abdomen. One of the most difficult, time-consuming, and sometimes unreliable parts of the case is closing these incisions, especially in obese patients. This is mainly because these incisions are very small and the layer that needs to be closed (fascia) rests deep underneath the skin and fat tissue of the abdominal wall. Two of the investigators (CM and BS) have developed at Stanford an instrument that allows for an easier and more reliable closure of these wounds. The purpose of this study is to test this instrument in the closure of laparoscopic wounds in obese patients undergoing laparoscopic gastric bypass surgery.
Detailed Description
For the patients enrolling in this study, preoperative and postoperative care will be exactly the same. The operative procedure will also be very similar with the only modification being in the way the ports are closed at the end of the surgery and the fact that all ports 11mm or greater will be closed (instead of leaving 11 or 12mm ports to be closed at the discretion of the surgeon). Instead of using a suture-passer to place the suture through the fascia, the surgeon will use the new instrument to drive the suture into the tissue under direct visualization through the umbilical port camera. The same instrument but with new sutures will be used for each of the interrupted stitches that are usually placed to close the port. The instrument that has been developed by some of the investigators is a 10mm elongated device that can easily be inserted into the port or fascial opening. If inserted through the port, the trocar can then be slid over the instrument to remove the trocar without losing pneumoperitoneum. The instrument has two opposing wings that will open once placed beyond the fascial opening. As the surgeon pulls up on the device, the wings open sliding along the fascia and pushing away any intra-abdominal contents that may be close to the instrument. Once the surgeon assures under direct visualization with the camera that the wings are open at both sides of the wound and that all intra-abdominal contents are out of the way (just as the surgeon would with the standard technique), he or she pushes a plunger that drives two flexible nitinol needles from the shaft of the instrument, through the fascia, and into the wings. The needles will be received in the wings by a set of couplers attached to the same suture that would be used otherwise (#0 Vycril). The surgeon then releases the wings and pulls out the device, leaving a looped suture placed around the opening. The surgeon can then tie the sutures as he or she would normally do on the standard procedure. At any time, the surgeon can reposition or remove the instrument without placing the sutures. The procedure may be repeated as many times as the surgeon considers necessary (usually 1 to close the 11 or 12mm fascial ports and 2 or 3 to close the 25mm fascial port).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hernia, Abdominal

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
4 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Gastric Bypass Surgery Patients
Arm Type
Experimental
Arm Description
Surgical site closure using Port Close device
Intervention Type
Device
Intervention Name(s)
Port Close
Intervention Description
Device for applying loop suture to close surgical site
Primary Outcome Measure Information:
Title
Count of Participants With Successful Port Site Closure Using Port Close Device
Time Frame
Day 1, at the end of surgery
Title
Time of Port Site Closure
Time Frame
Day 1, from insertion to removal of Port Close device during surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:- Clinical Diagnosis of Morbid Obesity BMI > 40 or BMI > 35 with medical comorbidities Undergoing laparoscopic gastric surgery Have at least one trocar site measuring 12 mm or greater Exclusion Criteria:Vulnerable subjects will be excluded including: Children Pregnant women Economically and educationally disadvantaged Decisionally impaired Homeless people Employees and students.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas M. Krummel
Organizational Affiliation
Stanford University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Stanford University School of Medicine
City
Stanford
State/Province
California
ZIP/Postal Code
94305
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Efficacy Study to Evaluate Laparoscopic Fascial Closure Device

We'll reach out to this number within 24 hrs